MIND MEDICINE MINDMED INC. [MMEDF: OTCQB]

1.5938 -0.0762 (-4.56%) 11/25/2020 Delayed 15 minutes

Open	$1.55	Daily Range	$1.36-$1.77
Prev. Close	$1.67	52 Week Range	$0.0833-$1.98
Volume	10,909,924

Quote Data Realtime

Inside Quote
Bid	Ask	Last Inside Change
$1.58 x 300 shares	$1.61 x 16514 shares	11/25 5:00 PM EST

Level II Quote Montage

BID

ASK

MMID	Bid Price	Bid Size	Date/Time
CDEL	1.58	300	11/25
VALX	1.57	16000	11/25
JANE	1.57	5000	11/25
INTL	1.57	20200	11/25
NITE	1.57	200	11/25
CSTI	1.57	200	11/25
GTSM	1.57	100	11/25
ETRF	1.56	100	11/25
OTCX	1.55	1600	11/25
LAFC	0.6572	1000	10/28
MAXM	0.6572	1000	11/25
MCAP	0.13	5000	11/25
PUMA	U		11/25
BGCE	U		11/25

MMID	Ask Price	Ask Size	Date/Time
INTL	1.61	6500	11/25
NITE	1.61	5014	11/25
GTSM	1.61	5000	11/25
VALX	1.62	24000	11/25
JANE	1.63	5000	11/25
ETRF	1.63	100	11/25
CDEL	1.70	550	11/25
CSTI	1.74	200	11/25
OTCX	1.80	500	11/25
MAXM	2.29	100	11/25
PUMA	2.58	100	11/25
MCAP	2.72	100	11/25
LAFC	3.02	100	11/20
BGCE	U		11/25

The quotes displayed here are published by market makers on the OTC Markets Group Inc. electronic inter-dealer quotation and trading system for OTC securities. Please see Terms of Service and Risk Warning for more information.

MMID - Market maker quotation published in OTC Link that meets the Inside market | MMID - Market maker quotation published in OTC Link | cMMID - Closed quote | Unpriced - Unpriced quote in OTC Link | MMIDu - Unsolicited market maker quotation published in OTC Link

forbes

This New York City Pharma Startup Wants To Turn LSD Into An FDA-Approved Medicine For Anxiety Disorder

Mind Medicine Inc., a New York-based psychedelic drug development company, that counts Shark Tank star Kevin O’Leary and Toms Shoes founder Blake Mycoskie as investors, has acquired the exclusive rights to eight clinical trials that are exploring the medicinal properties of the powerful hallucinogen lysergic acid diethylamide (LSD). One of the studies is an ongoing, placebo-controlled Phase 2 trial of LSD for the treatment of anxiety disorder.

read the full forbes article

https://www.forbes.com/sites/willyakowicz/2020/04/01/this-new-york-city-pharma-startup-wants-to-turn-lsd-into-an-fda-approved-medicine-for-anxiety-disorder/#754c87713293

This New York City Pharma Startup Wants To Turn LSD Into An FDA-Approved Medicine For Anxiety Disorder

Browse more articles